Christopher G. England

4.2k total citations · 2 hit papers
50 papers, 3.3k citations indexed

About

Christopher G. England is a scholar working on Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher G. England has authored 50 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Biomedical Engineering and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher G. England's work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Christopher G. England is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Christopher G. England collaborates with scholars based in United States, China and South Korea. Christopher G. England's co-authors include Weibo Cai, Emily B. Ehlerding, Haiming Luo, Dawei Jiang, Reinier Hernandez, Haiyan Sun, Todd E. Barnhart, Shreya Goel, Feng Chen and Stephen A. Graves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Christopher G. England

50 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence

2016 392 citations Christopher G. England, Emily B. Ehlerding et al. profile →
DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury

2018 359 citations Dawei Jiang, Hyung‐Jun Im et al. profile →

Peers

Countries citing papers authored by Christopher G. England

Since Specialization

Citations

This map shows the geographic impact of Christopher G. England's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. England with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. England more than expected).

Fields of papers citing papers by Christopher G. England

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. England. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. England. The network helps show where Christopher G. England may publish in the future.

Co-authorship network of co-authors of Christopher G. England

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. England. A scholar is included among the top collaborators of Christopher G. England based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. England. Christopher G. England is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models 2018 ·Cytokine ·Bai Liu, Monica Jones, Lin Kong, (unknown), Emily K. Jeng, Sixiang Shi, Christopher G. England, Sarah Alter, Jeffrey S. Miller, Weibo Cai, Peter R. Rhode, Hing C. Wong	30
2	ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Lei Kang, Dawei Jiang, Christopher G. England, Todd E. Barnhart, Bo Yu, Zachary T. Rosenkrans, Rongfu Wang, Jonathan W. Engle, Xiaojie Xu, Peng Huang, Weibo Cai	37
3	Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer 2017 ·European Journal of Nuclear Medicine and Molecular Imaging ·Dawei Jiang, Hyung‐Jun Im, Haiyan Sun, Hector F. Valdovinos, Christopher G. England, Emily B. Ehlerding, Robert J. Nickles, Dong Soo Lee, Steve Y. Cho, Peng Huang, Weibo Cai	30
4	ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836 2017 ·Journal of Controlled Release ·Reinier Hernandez, Christopher G. England, Yunan Yang, Hector F. Valdovinos, Bai Liu, Hing C. Wong, Todd E. Barnhart, Weibo Cai	17
5	Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer 2016 ·Clinical Cancer Research ·Haiming Luo, Christopher G. England, Sixiang Shi, Stephen A. Graves, Reinier Hernandez, Bai Liu, Charles P. Theuer, Hing C. Wong, Robert J. Nickles, Weibo Cai	30
6	ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Haiyan Sun, Christopher G. England, Reinier Hernandez, Stephen A. Graves, Rebecca Majewski, Anyanee Kamkaew, Dawei Jiang, Todd E. Barnhart, Yunan Yang, Weibo Cai	25
7	Long circulating reduced graphene oxide–iron oxide nanoparticles for efficient tumor targeting and multimodality imaging 2016 ·Nanoscale ·Cheng Xu, Sixiang Shi, Liangzhu Feng, Feng Chen, Stephen A. Graves, Emily B. Ehlerding, Shreya Goel, Haiyan Sun, Christopher G. England, Robert J. Nickles, Zhuang Liu, Taihong Wang, Weibo Cai	56
8	Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles 2016 ·Biomaterials ·Christopher G. England, Hyung‐Jun Im, Liangzhu Feng, Feng Chen, Stephen A. Graves, Reinier Hernandez, Hakan Orbay, Cheng Xu, Steve Y. Cho, Robert J. Nickles, Zhuang Liu, Dong Soo Lee, Weibo Cai	58
9	Biocompatibility and in vivo operation of implantable mesoporous PVDF-based nanogenerators 2016 ·Nano Energy ·Yanhao Yu, Haiyan Sun, Hakan Orbay, Feng Chen, Christopher G. England, Weibo Cai, Xudong Wang	160
10	Preclinical Pharmacokinetics and Biodistribution Studies of ⁸⁹Zr-Labeled Pembrolizumab 2016 ·Journal of Nuclear Medicine ·Christopher G. England, Emily B. Ehlerding, Reinier Hernandez, Brian T. Rekoske, Stephen A. Graves, Haiyan Sun, Glenn Liu, Douglas G. McNeel, Todd E. Barnhart, Weibo Cai	156
11	Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christopher G. England, Lixin Rui, Weibo Cai	19
12	Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics 2016 ·Advanced Drug Delivery Reviews ·Shreya Goel, Christopher G. England, Feng Chen, Weibo Cai	151
13	CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody 2016 ·Theranostics ·Reinier Hernandez, Haiyan Sun, Christopher G. England, Hector F. Valdovinos, Emily B. Ehlerding, Todd E. Barnhart, Yunan Yang, Weibo Cai	61
14	DNA nanomaterials for preclinical imaging and drug delivery 2016 ·Journal of Controlled Release ·Dawei Jiang, Christopher G. England, Weibo Cai	61
15	Evaluation of uptake and distribution of gold nanoparticles in solid tumors 2015 ·The European Physical Journal Plus ·Christopher G. England, André M. Gobin, Hermann B. Frieboes	32
16	Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging 2015 ·PLoS ONE ·Christopher G. England, (unknown), (unknown), Guandong Zhang, André M. Gobin, Hermann B. Frieboes	28
17	PET Imaging of VEGFR-2 Expression in Lung Cancer with ⁶⁴Cu-Labeled Ramucirumab 2015 ·Journal of Nuclear Medicine ·Haiming Luo, Christopher G. England, Stephen A. Graves, Haiyan Sun, Glenn Liu, Robert J. Nickles, Weibo Cai	33
18	A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity 2015 ·Current Drug Targets ·Christopher G. England, Chin K. Ng, Victor van Berkel, Hermann B. Frieboes	12
19	Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles 2013 ·International Journal of Nanomedicine ·Hermann B. Frieboes, Christopher G. England, (unknown), Guandong Zhang, Xinghua Sun, (unknown), Lacey R. McNally, Victor van Berkel, André M. Gobin	36
20	Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer 2013 ·PLoS Computational Biology ·James J. Lee, (unknown), Christopher G. England, Lacey R. McNally, Hermann B. Frieboes	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact